NCT06235203 2025-06-03
Neoadjuvant vs Adjuvant in Locally Advanced Recurrent NPC
Eye & ENT Hospital of Fudan University
Phase 3 Recruiting
Clinical Trials
13 trialsNCT05913037 2025-03-06
FCN-159 in Adult Patients With Symptomatic, Inoperable Neurofibromatosis Type 1-Related Plexiform Neurofibromas
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Phase 3 Active not recruiting
NCT05063136 2024-11-04
Adjuvant Metronomic Capecitabine Plus Endocrine Therapy for HR+/HER2- Primary Breast Cancer
Henan Cancer Hospital
Phase 3 Recruiting
NCT06642844 2024-10-15
PHARBEVACOL
University Hospital, Tours
Phase 3 Not yet recruiting
NCT06248996 2024-09-19
ARTSCAN VI
Lund University Hospital
Phase 3 Recruiting
NCT04385433 2023-08-24
PRAVAPREV-01
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 3 Terminated
NCT02870582 2022-11-29
Donafenib for Previously Treated Metastatic Colorectal Cancer
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 3 Completed
NCT04095455 2020-10-27
The Effect Of Ultrasound-guided Modified Pectoral Nerves Block Versus Ketamine Plus Magnesium Infusion On Analgesic Profile In Breast Cancer Surgeries
National Cancer Institute, Egypt
Phase 3 Unknown
NCT03971019 2019-08-14
SBSBC
Peking Union Medical College Hospital
Phase 3 Unknown
NCT03680261 2018-09-21
Enriched-CRT 2017: Advanced Gastric Cancer With LN+ and LVI+, Chemotherapy vs. Chemoradiotherapy
Shanghai Zhongshan Hospital
Phase 3 Unknown
NCT02891083 2016-09-07
Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal Cancer
Shanghai Chest Hospital
Phase 3 Unknown
NCT00726635 2009-02-17
The Assessment of Preoperative Psychological Intervention on Stress in Women With Gynecological Malignancies
Rabin Medical Center
Phase 3 Unknown
NCT00582244 2007-12-28
EVA project
The Netherlands Cancer Institute
Phase 3 Unknown